Amino Acid Nitrate Compositions for Vasodilation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional amino acids, nitrates, and nitrites have limitations such as slow vasodilating effects, high required doses, and poor bioavailability, which hinder their effectiveness in improving athletic performance and vasodilation in humans.
Innovation Solution
Development of amino acid compositions comprising amino acid nitrate or nitrite compounds, such as Arginine Nitrate, Citrulline Nitrate, and Creatine Nitrate, which are more water soluble and require lower doses to achieve enhanced vasodilation and improved bioabsorption, thereby overcoming the limitations of single administration forms.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional amino acids, nitrates, and nitrites are administered alone, then they can provide basic physiological functions, but they exhibit slow vasodilating effects, require high doses, and have poor bioavailability
Solution Approach 1:
The patent combines amino acids (arginine, citrulline, creatine) with nitrates or nitrites to form composite compounds. This merging creates a synergistic effect where the amino acid component enhances bioavailability and the nitrate/nitrite component provides rapid vasodilation, resolving the contradiction between reliability and productivity.
Solution Approach 2:
The invention creates composite chemical compounds by bonding amino acid molecules with nitrate or nitrite groups. These composite materials exhibit properties superior to their individual components, specifically achieving both high bioavailability (from the amino acid) and fast vasodilation (from the nitrate/nitrite), thus resolving the technical contradiction.
2Reliability
If conventional amino acids, nitrates, and nitrites are administered alone, then they can provide basic physiological functions, but they require high doses to achieve effective results
Solution Approach 1:
By merging amino acids with nitrates or nitrites into single composite compounds, the patent achieves synergistic effects that amplify potency. This allows effective therapeutic results at lower doses compared to administering separate amino acids and nitrates, resolving the contradiction between reliability and quantity of substance.
Solution Approach 2:
The invention changes the chemical parameters of the compounds by forming amino acid nitrate or nitrite derivatives. This parameter change (from separate molecules to bonded compounds) fundamentally alters bioavailability and potency characteristics, enabling effective doses to be reduced while maintaining or enhancing therapeutic reliability.
3Reliability
If conventional amino acids, nitrates, and nitrites are administered alone, then they can provide basic physiological functions, but they have poor bioavailability
Solution Approach 1:
The patent merges amino acids with nitrates or nitrites to create compounds that leverage the bioavailability-enhancing properties of amino acids while retaining the vasodilatory effects of nitrates/nitrites. This merging resolves the contradiction by making the nitrate/nitrite component more bioavailable through association with the amino acid structure.
Solution Approach 2:
The composite amino acid nitrate/nitrite compounds exhibit improved bioavailability characteristics compared to pure nitrates or nitrites. The amino acid portion of the composite material facilitates better absorption and utilization by the body, thus resolving the contradiction between reliability and ease of operation (bioavailability).
Data Source
AI summary
Compositions and supplement formulations comprise at least one of Carnitine, Taurine, or derivative forms thereof. In one aspect, the composition or a supplement formulation comprises at least one Amino Acid constituent selected from the group consisting of Carnitine, Taurine, and derivative forms thereof; and at least one Nitrate constituent. In another aspect, the composition or a supplement formulation comprises a Nitrate of a compound selected from the group consisting of Carnitine, Taurine, and derivative forms thereof, wherein the Nitrate is a salt of Nitrate or a mixed salt of Nitrate. The compositions and supplement formulations may be formulated for improving athletic performance, increasing the bioabsorption of Carnitine, Taurine, or derivative forms thereof, or for increasing the vasodilative characteristics.